138 related articles for article (PubMed ID: 21811050)
1. Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate.
Merola E; Sbrozzi-Vanni A; Panzuto F; D'Ambra G; Di Giulio E; Pilozzi E; Capurso G; Lahner E; Bordi C; Annibale B; Delle Fave G
Neuroendocrinology; 2012; 95(3):207-13. PubMed ID: 21811050
[TBL] [Abstract][Full Text] [Related]
2. Management and clinical outcomes of type I gastric carcinoid patients: retrospective, multicenter study in Japan.
Sato Y; Imamura H; Kaizaki Y; Koizumi W; Ishido K; Kurahara K; Suzuki H; Fujisaki J; Hirakawa K; Hosokawa O; Ito M; Kaminishi M; Furuta T; Chiba T; Haruma K
Dig Endosc; 2014 May; 26(3):377-84. PubMed ID: 24188531
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features and prognosis of different gastric carcinoid subtypes].
Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835
[TBL] [Abstract][Full Text] [Related]
4. Defining surgical indications for type I gastric carcinoid tumor.
Gladdy RA; Strong VE; Coit D; Allen PJ; Gerdes H; Shia J; Klimstra DS; Brennan MF; Tang LH
Ann Surg Oncol; 2009 Nov; 16(11):3154-60. PubMed ID: 19727959
[TBL] [Abstract][Full Text] [Related]
5. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
6. En-bloc resection of multiple type 1 gastric carcinoid tumors by endoscopic multi-band mucosectomy.
Hopper AD; Bourke MJ; Hourigan LF; Tran K; Moss A; Swan MP
J Gastroenterol Hepatol; 2009 Sep; 24(9):1516-21. PubMed ID: 19743997
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic submucosal resection with a ligation device is an effective and safe treatment for carcinoid tumors in the lower rectum.
Mashimo Y; Matsuda T; Uraoka T; Saito Y; Sano Y; Fu K; Kozu T; Ono A; Fujii T; Saito D
J Gastroenterol Hepatol; 2008 Feb; 23(2):218-21. PubMed ID: 18289355
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis].
Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J
Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917
[TBL] [Abstract][Full Text] [Related]
9. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
10. [Endoscopic treatment of gastric carcinoid. Report of a clinical case].
Romano G; Cocchiara G; Cajozzo M; Di Bernardo C; Buscemi G; Agrusa A; Maresi E; Diana G
Chir Ital; 2003; 55(4):601-4. PubMed ID: 12938611
[TBL] [Abstract][Full Text] [Related]
11. Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses.
Kim BS; Oh ST; Yook JH; Kim KC; Kim MG; Jeong JW; Kim BS
Am J Surg; 2010 Sep; 200(3):328-33. PubMed ID: 20385369
[TBL] [Abstract][Full Text] [Related]
12. [Long-term efficacy of endoscopic excision of rectal carcinoids].
Zhang YQ; Zhou PH; Xu MD; Zhong YS; Chen WF; Ma LL; Qin WZ; Cai XL; Yao LQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):421-3. PubMed ID: 18803040
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic treatment of gastric carcinoids.
Spinelli P; Cerrai FG; Casella G; Pizzetti P
Minerva Chir; 1994 Apr; 49(4):271-3. PubMed ID: 8072701
[TBL] [Abstract][Full Text] [Related]
14. Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis.
Massironi S; Zilli A; Fanetti I; Ciafardini C; Conte D; Peracchi M
Dig Liver Dis; 2015 Nov; 47(11):978-83. PubMed ID: 26321479
[TBL] [Abstract][Full Text] [Related]
15. [The prognosis of carcinoid tumors of the stomach].
Stolte M; Ebert D; Seifert E; Schulte F; Rode J
Leber Magen Darm; 1988 Sep; 18(5):246-50, 253-6. PubMed ID: 3054376
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis.
Vannella L; Lahner E; Osborn J; Bordi C; Miglione M; Delle Fave G; Annibale B
Aliment Pharmacol Ther; 2010 May; 31(9):1042-50. PubMed ID: 20175768
[TBL] [Abstract][Full Text] [Related]
17. Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer.
Doornebosch PG; Ferenschild FT; de Wilt JH; Dawson I; Tetteroo GW; de Graaf EJ
Dis Colon Rectum; 2010 Sep; 53(9):1234-9. PubMed ID: 20706065
[TBL] [Abstract][Full Text] [Related]
18. Rectal carcinoid tumors: review of results after endoscopic and surgical therapy.
Kwaan MR; Goldberg JE; Bleday R
Arch Surg; 2008 May; 143(5):471-5. PubMed ID: 18490556
[TBL] [Abstract][Full Text] [Related]
19. Total gastrectomy for type 1 gastric carcinoid: an unusual surgical indication?
Clemente G; Sarno G; Giordano M; De Rose AM; Giovannini I; Vecchio FM; Nuzzo G
Minerva Chir; 2007 Oct; 62(5):421-4. PubMed ID: 17947953
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic submucosal dissection for residual/local recurrence of early gastric cancer after endoscopic mucosal resection.
Oka S; Tanaka S; Kaneko I; Mouri R; Hirata M; Kanao H; Kawamura T; Yoshida S; Yoshihara M; Chayama K
Endoscopy; 2006 Oct; 38(10):996-1000. PubMed ID: 17058164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
